Pentagon says expanded screening is intended to identify health issues that could affect readiness...

The Pentagon has introduced new clinical guidelines requiring all active-duty and reserve service members aged 30 and older to undergo mandatory testosterone deficiency screening. This policy, announced by Defense Secretary Pete Hegseth in July, aims to ensure troops maintain optimal hormone levels for long-term health and operational readiness. Men with low testosterone may be offered voluntary hormone replacement therapy if clinically appropriate. The guidelines exclude women from routine testosterone testing but include screenings for hormonal issues affecting female service members, such as fatigue and menstrual irregularities. Critics argue the policy lacks sufficient evidence to justify universal screening, warning of potential over-treatment and unnecessary medical interventions. Experts note that testosterone levels naturally decline with age, but the military's focus on hormone regulation raises questions about its impact on troop welfare and readiness. The Food and Drug Administration plans to discuss testosterone use in military contexts later this month. While the policy emphasizes health optimization for service members, concerns persist about its practical benefits versus potential risks.

U.S. Secretary of Defense Pete Hegseth's controversial testosterone testing policy for service members over 30 has faced backlash from medical experts and legal challenges. The initiative, part of his 'High-T Department of War' program, requires annual testosterone level checks, sparking debates about its impact on military personnel. Medical professionals argue the policy could reduce male soldiers' fertility due to testosterone replacement therapy's effects on sperm counts. Dr. Adrian Dobs of Johns Hopkins University warned that mandatory testing produces unreliable results since hormone levels fluctuate based on time of day and meals, risking unnecessary hormone treatments for healthy troops. A federal judge has ordered the Trump administration to justify how the policy aligns with existing bans on hormone treatment for transgender service members. Critics highlight potential legal and health risks, questioning whether the policy prioritizes political agendas over military readiness. The controversy underscores growing tensions between defense policies and medical ethics in the U.S. military.

YouTube video by CNN